DISCOVER MORE
Our Corporate Access Portal serves as a tool to inform and engage investors by providing in-depth investor profiles for selected public companies and aims to facilitate meaningful one-on-one meetings between investors and company executives.
Investors can unlock captivating fireside chats and company webcasts; discover insightful KOL panels with public company executives and industry experts; and stay informed with real-time stock data, SEC filings, press releases and more.
Explore our Featured Companies and schedule your one-on-one meetings today!
From funding tailwinds to accelerating technology adoption, the Healthcare IT sector is entering a pivotal phase. In this video, Allen Klee of Maxim Group examines where the industry stands in the cycle, how federal initiatives and emerging technologies like AI are shaping adoption, and where investors may find compelling opportunities across the healthcare IT landscape.
RECENT NEWS
IRADIMED CORPORATION to Hold Fourth Quarter and Full Year 2025 Financial Results Conference Call on February 10, 2026
ORLANDO, Fla., Feb. 04, 2026 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2025...
Aytu BioPharma Reports Fiscal 2026 Second Quarter Operational and Financial Results
Total net revenue of $15.2 millionAdjusted EBITDA1 of $(0.8) million, which includes EXXUA launch investments$30.0 million cash balance at...
SenesTech’s Evolve® Approved in New Zealand
Supporting New Zealand's Predator Free 2050 Initiative Initial Stocking Order Fulfilled PHOENIX, Feb. 2, 2026 /PRNewswire/ -- SenesTech, Inc....
RECENT EVENTS
Aytu BioPharma (AYTU) Fireside Chat
Aytu BioPharma (Nasdaq: AYTU) is a pharmaceutical company focused on advancing innovative medicines for complex central nervous system...
Cadrenal Therapeutics (CVKD) Fireside Chat
Cadrenal Therapeutics, Inc. (Nasdaq: CVKD) is developing differentiated products designed to bridge critical gaps in current acute and chronic...
Alpha Tau (DRTS) Fireside Chat
Alpha Tau Medical (Nasdaq: DRTS) is the first company to develop a cancer therapy that releases an alpha radiating material for diffusion into...
